Skip to main content
Clinical Trials/NCT03742219
NCT03742219
Terminated
Not Applicable

Longitudinal Evaluation of Disease Prevalence in Impoverished Communities of Lima, Peru

Ohio University1 site in 1 country861 target enrollmentJune 5, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Diseases
Sponsor
Ohio University
Enrollment
861
Locations
1
Primary Endpoint
Weight
Status
Terminated
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the change in disease prevalence over time in impoverished urban communities in Lima, Peru.

Detailed Description

The aim is to track the changes in disease prevalence of people living in impoverished urban communities in Lima over the next 10 years. Based on data collected in prior years and in an ongoing manner, Ohio University Global Health teams will be introducing interventions focused to positively impact disease states and trends in this population. The current focus is on chronic lifestyle related diseases and their precursors: cardiovascular disease, hypertension, dyslipidemia, diabetes, and overweight / obesity.

Registry
clinicaltrials.gov
Start Date
June 5, 2017
End Date
March 1, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

David Drozek

Associate Professor

Ohio University

Eligibility Criteria

Inclusion Criteria

  • minors age 12-17 presenting to the free community clinic, with a responsible adult who can give consent; minors will give assent.
  • consenting adults of any age who present to the clinic.

Exclusion Criteria

  • adults who are unable to give consent.

Outcomes

Primary Outcomes

Weight

Time Frame: yearly for 10 years

weight in kilograms will be utilized to determine body mass index

Systolic blood pressure

Time Frame: yearly for 10 years

measured with a manual sphygmomanometer in millimeters of mercury

glycosylated hemoglobin

Time Frame: periodically over 10 years

measured in percent via fingerstick capillary blood and portable analyzer

Total cholesterol

Time Frame: periodically over 10 years

measured in percent via fingerstick capillary blood and portable analyzer

High density lipoprotein cholesterol

Time Frame: periodically over 10 years

measured in percent via fingerstick capillary blood and portable analyzer

Diastolic Blood Pressure

Time Frame: yearly for 10 years

measured with a manual sphygmomanometer in millimeters of mercury

Low-density lipoprotein cholesterol

Time Frame: periodically over 10 years

measured in percent via fingerstick capillary blood and portable analyzer

Triglycerides

Time Frame: periodically over 10 years

measured in percent via fingerstick capillary blood and portable analyzer

Secondary Outcomes

  • Household hunger scale(yearly for 10 years)
  • Patient Health Questionnaire - 4 (PHQ-4)(yearly for 10 years)
  • Perceived Stress Scale(yearly for 10 years)
  • Exercise vital sign(yearly for 10 years)
  • Herth Hope Index(yearly for 10 years)
  • 24 hour dietary recall(yearly for 10 years)

Study Sites (1)

Loading locations...

Similar Trials